Oxidative stress and cancer: the role of Nrf2 S Sajadimajd, M Khazaei Current cancer drug targets 18 (6), 538-557, 2018 | 334 | 2018 |
Advances on natural polyphenols as anticancer agents for skin cancer S Sajadimajd, R Bahramsoltani, A Iranpanah, JK Patra, G Das, S Gouda, ... Pharmacological research 151, 104584, 2020 | 186 | 2020 |
Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy H Derakhshankhah, S Sajadimajd, S Jafari, Z Izadi, S Sarvari, M Sharifi, ... Nanomedicine: Nanotechnology, Biology and Medicine 24, 102149, 2020 | 49 | 2020 |
Characterization and anti-diabetic effects of the oligosaccharide fraction isolated from Rosa canina in STZ-Induced diabetic rats M Rahimi, S Sajadimajd, Z Mahdian, M Hemmati, P Malekkhatabi, ... Carbohydrate research 489, 107927, 2020 | 35 | 2020 |
Involvement of TGF-β and autophagy pathways in pathogenesis of diabetes: a comprehensive review on biological and pharmacological insights F Heydarpour, S Sajadimajd, E Mirzarazi, P Haratipour, T Joshi, ... Frontiers in pharmacology 11, 498758, 2020 | 34 | 2020 |
Momordica charantia reverses type II diabetes in rat H Malekshahi, G Bahrami, S Miraghaee, SA Ahmadi, S Sajadimajd, ... Journal of food biochemistry 43 (11), e13021, 2019 | 25 | 2019 |
Sensitizing effect of juglone is mediated by down regulation of Notch1 signaling pathway in trastuzumab-resistant SKBR3 cells S Sajadimajd, R Yazdanparast Apoptosis 22, 135-144, 2017 | 22 | 2017 |
Molecular mechanisms underlying cancer preventive and therapeutic potential of algal polysaccharides S Sajadimajd, S Momtaz, P Haratipour, FF El-Senduny, AI Panah, ... Current Pharmaceutical Design 25 (11), 1210-1235, 2019 | 21 | 2019 |
Augmentation of oxidative stress-induced apoptosis in MCF7 cells by ascorbate–tamoxifen and/or ascorbate–juglone treatments S Sajadimajd, R Yazdanparast, F Roshanzamir In Vitro Cellular & Developmental Biology-Animal 52, 193-203, 2016 | 21 | 2016 |
Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina G Bahrami, SS Miraghaee, B Mohammadi, MT Bahrami, G Taheripak, ... Research in Pharmaceutical Sciences 15 (1), 36-47, 2020 | 20 | 2020 |
Plant-derived supplementary carbohydrates, polysaccharides and oligosaccharides in management of diabetes mellitus: A comprehensive review S Sajadimajd, G Bahrami, M Daglia, SM Nabavi, R Naseri, MH Farzaei Food Reviews International 35 (6), 563-586, 2019 | 20 | 2019 |
Targeting common signaling pathways for the treatment of stroke and Alzheimer’s: A comprehensive review S Eskandari, S Sajadimajd, L Alaei, Z Soheilikhah, H Derakhshankhah, ... Neurotoxicity research 39 (5), 1589-1612, 2021 | 15 | 2021 |
Association between human papillomavirus and transitional cell carcinoma of the bladder P Abdollahzadeh, SH Madani, S Khazaei, S Sajadimajd, B Izadi, F Najafi Urology journal 14 (6), 5047-5050, 2017 | 15 | 2017 |
Differential behaviors of trastuzumab-sensitive and-resistant SKBR3 cells treated with menadione reveal the involvement of Notch1/Akt/FOXO1 signaling elements S Sajadimajd, R Yazdanparast Molecular and cellular biochemistry 408, 89-102, 2015 | 15 | 2015 |
Anti-diabetic effect of a novel oligosaccharide isolated from Rosa canina via modulation of DNA methylation in Streptozotocin-diabetic rats G Bahrami, S Sajadimajd, B Mohammadi, R Hatami, S Miraghaee, ... DARU Journal of Pharmaceutical Sciences 28, 581-590, 2020 | 14 | 2020 |
Protective effects of 1,3‐diaryl‐2‐propen‐1‐one derivatives against H2O2‐induced damage in SK‐N‐MC cells S Bayati, R Yazdanparast, SS Majd, S Oh Journal of Applied Toxicology 31 (6), 545-553, 2011 | 14 | 2011 |
Involvement of Numb-mediated HIF-1α inhibition in anti-proliferative effect of PNA-antimiR-182 in trastuzumab-sensitive and-resistant SKBR3 cells S Sajadimajd, R Yazdanparast, S Akram Tumor Biology 37, 5413-5426, 2016 | 13 | 2016 |
Codelivery of resveratrol melatonin utilizing pH responsive sericin based nanocarriers inhibits the proliferation of breast cancer cell line at the different pH F Aghaz, Z Asadi, S Sajadimajd, K Kashfi, E Arkan, Z Rahimi Scientific Reports 13 (1), 11090, 2023 | 11 | 2023 |
Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes H Derakhshankhah, S Sajadimajd, F Jahanshahi, Z Samsonchi, H Karimi, ... Tissue Engineering Part B: Reviews 28 (5), 1053-1066, 2022 | 11 | 2022 |
Novel elastomeric fibrous composites of poly-ε-caprolactone/propolis and their evaluation for biomedical applications R Mohamadinooripoor, S Kashanian, P Moradipour, S Sajadimajd, ... Journal of Polymer Research 29 (8), 313, 2022 | 11 | 2022 |